Main menu
Click categories to expand
A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing
This is an alphabetical index of all content pages.
Other categories
Utilities
Also see
Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy
Twitter feed ð•
Feeds + s.e.o. etc.
rss / xml feed 
sitemap file
A-Z listing (archived)
Cannabidiol is an extract of the Cannabis plant which was licenced in the US in 2018 for use as a treatment for various types of Epilepsyplugin-autotooltip__plain plugin-autotooltip_bigEpilepsy
"Epilepsy is a chronic noncommunicable disease of the brain that affects around 50 million people worldwide. It is characterized by recurrent seizures, which are brief episodes of involuntary movement that may involve a part of the body (partial) or the entir…
It's also used to treat Restless leg syndromeplugin-autotooltip__plain plugin-autotooltip_bigRestless leg syndrome
Restless legs syndrome, also known as Willis-Ekbom disease, is a common condition of the nervous system that causes an overwhelming and irresistible urge to move the legs. Estimates are that around 10% of people suffer from RLS at some stage in th… and some other movement disorders.
Despite intensive research efforts (it was first isolated in 1940) its 'mechanism of action' in successfully treating a range of neurological disorders is currently unknown.
There is still some debate about scientific proof of its efficacy in treatments of anxiety, nausea, glaucoma, chronic pain and as an anti-psychotic. Nevertheless, its use - both formally and informally - is now very widespread, and it's no longer a restricted substance in many countries.
Technical info.: Epilepsia . 2014 Jun; 55(6): 791–802.
Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.
DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023